Log In
Print this Print this

Actiq, fentanyl (TA-8317)

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionOral transmucosal form of fentanyl citrate
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsManage breakthrough pain; Treat breakthrough cancer pain; Treat cancer pain; Treat chronic breakthrough pain in cancer
Regulatory Designation
PartnerDompe Farmaceutici S.p.A.;
Mitsubishi Tanabe Pharma Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today